EMPOWER: Using Patient and Breast Cancer Disease Characteristics to Direct Combination Therapy in the Treatment of Metastatic HRPositive, HER2-Negative Breast Cancer





Wednesday, February 20, 2019

5:30PM – 6:00PM : Registration and Dinner
6:00PM – 8:30PM : CME Presentation

JW Marriott Marquis Miami
255 Biscayne Blvd Way
Miami, FL 33131
Meeting Room: Junior Ballroom

Program Features

  • Virtual reality animation
  • Create your own Personalized Poster Online Portal
  • iPads provided to enhance learning experience


Joyce O’Shaughnessy, MD
Celebrating Women Chair in Breast Cancer Research
Baylor University Medical Center
Texas Oncology
US Oncology Network
Dallas, TX

Mohammad Jahanzeb, MD, FACP
Professor of Clinical Medicine, Hematology-Oncology
Medical Director, USylvester Deerfield Beach
Associate Director of Community Outreach
University of Miami
Miami, FL

Learning Objectives

After completing the CME activity, learners should be better able to:

  • Describe the involvement of CDKs and cyclins in the uncontrolled cellular proliferation characteristic of breast cancer
  • Review how to use patient and disease characteristics to identify the individual with advanced, HR+ breast cancer who would benefit from the use of CDK 4/6 inhibition
  • Analyze the properties of CDK 4/6 inhibitors and the potential pharmacodynamic effects in patients with hormone receptor positive, HER2-negative advanced breast cancer
  • Discuss the application of CDK 4/6 inhibitor clinical trial data to the management of breast cancer patients in a community oncology practice
  • Explain the patient’s and healthcare team’s responsibilities that will foster a multidisciplinary effort to optimize outcomes

Target Audience

This CME initiative is designed to meet the educational needs of medical oncologists, nurse practitioners, nurses, pharmacists, and other healthcare providers involved in the treatment of patients with hormone receptor-positive, HER2-negative advanced breast cancer.

Accreditation Statement

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.


Med Learning Group designates this live activity for a maximum of 2.5 AMA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.


This program would be beneficial for nurses involved in the care of patients with Breast Cancer.

2.5 ANCC Contact Hour(s)

Accreditation Statement:

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Awarded 2.5 contact hour(s) of continuing nursing education of RNs and APNs.


In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.


Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact: Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at: http://www.medlearninggroup.com/privacy-policy/


Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Feel free to pass this invitation on to your physicians, fellows, physician assistants, nurses, pharmacists, healthcare practitioners, and any other colleagues that you believe would be interested in attending this free CME/CNE program.





Copyright © 2018 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.